Assyro AI

Orange Book product · Brand (NDA)

QUARTETTE

ETHINYL ESTRADIOL; LEVONORGESTREL

Brand (NDA)NDA 204061TE ABRX TEVA BRANDED PHARM

At a glance

Mar 28, 2013

Approved

Brand (NDA)

Application

AB

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 28, 2013

    13 yr 5 mo ago

  2. Today

  3. Patent 8415332 expires

    Listed drug product patent expiration.

    Mar 11, 2029

    in 2 yr 9 mo

Pharmaceutical detail

Active ingredient

ETHINYL ESTRADIOL; LEVONORGESTREL

Strength

0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 204061

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8415332Mar 11, 2029in 2 yr 9 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.